Skip to content

LEEMAN APOTHEEK

Active
Private limited companyfounded 1996active for 30 yearsFuchsiasstraat 13, 1080 Sint-Jans-Molenbeek, BelgiumKBO/BCE: BE 0458.661.827
Summary

LEEMAN APOTHEEK has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €18,993 and a net result of €78,326. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 26% of 22,238 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€310,011total assets 2025
Equity
€18,993
Profit
€78,326
Turnover not published (abbreviated or micro format)
Financial health
84 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.4%
Structure
Parent
MAUDENS JEROEN · 99%
  • MAUDENS JEROENDirector
Accounts 30 days early1 of 3 deeds read
Why 84raises riskSector: Retail trade (NACE 47)Equity €18,993 (6.1% of total assets)lowers riskSize: total assets €310,011Founded in 1996Show the evidence

Checked score

Score 2025
84 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 58% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Average
Solvency 31+6
equity 6.1% of total assets
Liquidity 15-3
short-term debt 76.3% · cash 5.0%
Profitability 100=
return on assets 25.3%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,188 companies, NACE 47, micro)
Last 24 months 11-2024: 0.8% 12-2024: 0.8%● unchanged vs 11-2024 01-2025: 0.8%● unchanged vs 12-2024 02-2025: 0.8%● unchanged vs 01-2025 03-2025: 0.8%● unchanged vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025highest value 06-2025: 0.5%▼ -0.3 percentage points vs 05-2025 07-2025: 0.5%● unchanged vs 06-2025 08-2025: 0.5%● unchanged vs 07-2025 09-2025: 0.5%● unchanged vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.4%▼ -0.1 percentage points vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.5%▲ +0.1 percentage points vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.4%▼ -0.1 percentage points vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.4%▼ -0.1 percentage points vs 07-2026lowest value 09-2026: 0.4%● unchanged vs 08-2026lowest value 10-2026: 0.4%● unchanged vs 09-2026lowest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity tight (current ratio 1.1, compared with 1.23 in 2024; short-term debt: 76.3% and cash: 5% of total assets), and 93.9% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 23% on solvency, 14% on liquidity, 96% on profitability and 99% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €310,011
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1996
How long the company has existed counts in the probability; how much depends on the rest of its profile.
KBO
raises risk · Equity €18,993 (6.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
30 days early
2024
71 days early
2023
41 days early
2022
39 days early
2021
34 days early
2020
24 days early
2019
5 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 35 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 22 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
10-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Resignation: MAUDENS JEROEN (manager)Appointment: MAUDENS JEROEN (non-statutory director)…
  3. Highest result from 2018 to 2025net €78,326 ▲9.8%

Key points

  • Positive: Among the best 7% on net resultsector median €5,031 · 22,218 companies €78,326 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Controlled by MAUDENS JEROEN 99% View
  • New directorlatest change 29-05-2026 · 1 in office 1 joined View

By topic

Financials

Financial year
2025
Total assets
€310,011
Profit
€78,326
Solvency
6.1%
Total assets▲ 24.4%
Net result
20182025
Go to Financials

Timeline

Events
33
Since
1998
Next accounts
by 31-07-2027
  1. 21-05-2025Annual accounts filed
  2. 20-06-2024Annual accounts filed
  3. 22-06-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
21-08-1996
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.